Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Cancer ; 75(2 Suppl): 613-36, 1995 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-7804987

RESUMO

Cutaneous melanoma (CM) and nonmelanoma skin cancer (NMSC) have a high chance for cure if detected in an early phase of development. Patients who have these tumors may now be treated in the outpatient setting with a minimum of discomfort, inconvenience, and cost. Most skin cancer deaths are caused by CM. Until recently, CM incidence in the United States has been increasing faster than any other potentially lethal cancer, attributable at least in part to aggressive case detection and greater public awareness about the significance of risk factors and early warning signs of evolving tumors, resulting in increased numbers of curable tumors. Most CMs are discovered by patients or close acquaintances. Most CM deaths are related to patient delay in seeking medical care. Patient delay is attributed mostly to lack of knowledge rather than to fear and denial. In the United States, primary prevention of CM and NMSC has focused on encouraging sensible sun-exposure behaviors, while secondary prevention consists of a yearly national campaign that promotes skin awareness and self-examination and free examinations to detect evolving tumors, sponsored by the American Academy of Dermatology and the American Cancer Society. More attention is needed to encourage timely consultation for evolving tumors and predisposing risk factors and to focus screening and surveillance efforts of those people at greatest risk. Public education must continue to promote personal responsibility in the intervention process to reduce the morbidity and mortality associated with CM and NMSC.


Assuntos
Educação em Saúde/métodos , Melanoma/prevenção & controle , Neoplasias Cutâneas/prevenção & controle , Carcinoma Basocelular/diagnóstico , Carcinoma Basocelular/epidemiologia , Carcinoma Basocelular/prevenção & controle , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/epidemiologia , Carcinoma de Células Escamosas/prevenção & controle , Feminino , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Incidência , Masculino , Programas de Rastreamento , Melanoma/diagnóstico , Melanoma/epidemiologia , Autoexame , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/epidemiologia , Raios Ultravioleta/efeitos adversos , Estados Unidos/epidemiologia
2.
J Am Acad Dermatol ; 26(5 Pt 2): 882-4, 1992 May.
Artigo em Inglês | MEDLINE | ID: mdl-1613155

RESUMO

A 71-year-old white woman had finely wrinkled, erythematous patches of skin that met the clinical and histologic criteria for mid-dermal elastolysis. In addition to the loss of mid-dermal elastin described in previous cases, histopathologic examination revealed a superficial and deep perivascular inflammatory infiltrate of lymphocytes and plasma cells and interstitial collections of multinucleated giant cells containing phagocytized elastin. These results support a previously postulated inflammatory pathogenesis for mid-dermal elastolysis.


Assuntos
Cútis Laxa/diagnóstico , Dermatite/diagnóstico , Tecido Elástico/patologia , Eritema/diagnóstico , Dermatoses da Perna/diagnóstico , Idoso , Atrofia/etiologia , Cútis Laxa/complicações , Cútis Laxa/patologia , Dermatite/complicações , Dermatite/patologia , Eritema/complicações , Eritema/patologia , Feminino , Antebraço , Humanos , Dermatoses da Perna/complicações , Dermatoses da Perna/patologia , Pele/patologia , Coxa da Perna
3.
In. World Congress of Dermatology, 17; Orfanos, C. E; Stadler, R; Gollnick, H. World Congress of Dermatology, 17/Proceedings. Berlin, Spring Verlag, May 1988. p.346-54, tab.
Não convencional em Inglês | Sec. Est. Saúde SP, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1245750
4.
J Pediatr ; 100(2): 219-24, 1982 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-7057329

RESUMO

The relative risk of melanoma associated with small congenital nevi was estimated by comparing the published frequency of histologically documented nevocellular nevi in newborn infants with the frequency of: (1) congenital nevi at the tumor site, ascertained by history in 134 patients with melanoma; and (2) tumor-associated nevi with congenital features in 234 melanoma specimens. A 21-fold increase in melanoma risk was estimated for persons with small congenital nevi when nevi were ascertained by history, and a three- to tenfold increase in risk when nevi were ascertained by histology. Based on these approximations of relative risk from historic and histologic methods of detection, persons with small congenital nevi who live to age 60 are estimated to have cumulative risks for melanoma of 4.9/100 and 0.8 to 2.6/100, respectively. The increased risk is related presumably to the markedly increased probability of melanoma arising in association with small congenital nevi. In other words, small congenital nevi may represent precursors for at least some cases of cutaneous melanoma. The estimated risk are highly dependent on the specificity of methods used for ascertainment of congenital nevi.


Assuntos
Síndrome do Nevo Basocelular/congênito , Carcinoma Basocelular/congênito , Melanoma/congênito , Neoplasias Cutâneas/congênito , Adolescente , Adulto , Idoso , Envelhecimento , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Anamnese , Pessoa de Meia-Idade , Nevo Pigmentado/congênito , Risco , Pele/anatomia & histologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA